Published in Br J Urol on August 01, 1982
The natural history of untreated "prostatism". Br J Urol (1981) 2.22
Magnetic resonance imaging in the identification of an otherwise undetectable upper pole moiety. Br J Urol (1993) 2.04
A non-circadian role for cAMP signaling and CREB activity in Drosophila rest homeostasis. Nat Neurosci (2001) 1.95
Sequences flanking the centromere of human chromosome 10 are a complex patchwork of arm-specific sequences, stable duplications and unstable sequences with homologies to telomeric and other centromeric locations. Hum Mol Genet (1999) 1.94
Selective mating, assortative mating, and inbreeding: definitions and implications. Eugen Q (1968) 1.85
Urinary incontinence: prevalence and needs. Br J Urol (1979) 1.75
Chronic testicular pain following vasectomy. Br J Urol (1992) 1.71
Hesitancy and poor stream in younger men without outflow tract obstruction--the anxious bladder. Br J Urol (1979) 1.70
Nitrogen metabolite signalling involves the C-terminus and the GATA domain of the Aspergillus transcription factor AREA and the 3' untranslated region of its mRNA. EMBO J (1996) 1.58
Chronic testicular pain: an overview. Eur Urol (2004) 1.57
Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle. J Clin Invest (1996) 1.56
Endoscopy-based triage significantly reduces hospitalization rates and costs of treating upper GI bleeding: a randomized controlled trial. Gastrointest Endosc (1999) 1.53
The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol (1979) 1.50
The changing role of surgery in metastatic non-seminomatous germ cell tumour. Br J Cancer (1992) 1.49
How should new treatments for benign prostatic hyperplasia be assessed? BMJ (1993) 1.46
Long-term follow-up of transvaginal urethral closure and suprapubic cystostomy for urinary incontinence in women with multiple sclerosis. Br J Urol (1994) 1.39
The clinical implications of the prostate cancer prevention trial. BJU Int (2003) 1.38
Bilateral testicular cancer: a preventable problem? Experience from a large cancer centre. BJU Int (2003) 1.38
Partial extraction of double-J stent during nephrostomy tube removal and its prevention. Br J Urol (1991) 1.37
The actions of prostaglandins on the smooth muscle of the human urinary tract in vitro. Br J Urol (1975) 1.37
A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer. Radiother Oncol (1994) 1.37
Effects of low temperature on the respiratory metabolism of carbohydrates by plants. Symp Soc Exp Biol (1988) 1.30
GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol (1998) 1.24
Acute urinary retention--a urodynamic assessment. Br J Urol (1984) 1.20
Bacteriological survey of acute appendicitis in children. Br J Surg (1976) 1.20
Terazosin in the treatment of benign prostatic hyperplasia: a multicentre, placebo-controlled trial. Br J Urol (1992) 1.18
Spontaneous regression of metastatic renal carcinoma. Br J Surg (1987) 1.17
Hormonal regulation of human endometrial stromal cells in culture: an in vitro model for decidualization. Fertil Steril (1989) 1.14
Idiopathic bladder instability treated by biofeedback. Br J Urol (1978) 1.14
Electrical activity of human colonic smooth muscle in vitro. J Physiol (1978) 1.12
Microtransducer urethral profile methodology: variations caused by transducer orientation. J Urol (1983) 1.11
Re: Immediate versus deferred treatment for advanced prostate cancer: initial results of the medical research council trial. J Urol (1998) 1.07
Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators Group. Semin Oncol (1993) 1.06
Long-term catheterization of the bladder: prevalence and morbidity. Br J Urol (1996) 1.06
Vesico-intestinal fistulae. Br J Surg (1972) 1.05
Normal human endometrium in cell culture. Methods Cell Biol (1980) 1.04
Effects of a low-oestrogen oral contraceptive on urinary excretion of luteinizing hormone and ovarian steroids. Br Med J (1974) 1.03
Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer. Oncogene (2010) 1.02
Patterns of survival and reproduction in the United States: implications for selection. Proc Natl Acad Sci U S A (1968) 1.02
Who should have a prostatectomy? A survey of the management of patients presenting with bladder outflow obstruction. J R Soc Med (1991) 1.02
Anomalous cellular proliferation in vitro associated with Huntington's disease. Hum Genet (1977) 1.00
The management of female incontinence by suprapubic catheterisation, with or without urethral closure. Br J Urol (1983) 1.00
Multicentre survey of urinary tract infections in general practice. Clinical trial of single dose treatment with sulfametopyrazine (Kelfizine-W). Br J Urol (1972) 0.99
Normal human endometrium in cell culture. I. Separation and characterization of epithelial and stromal components in vitro. In Vitro (1978) 0.96
Improving the management of superficial bladder cancer. BMJ (1993) 0.96
Endorphins--a role in lower urinary tract function? The effect of opioid blockade on the detrusor and urethral sphincter mechanisms. Br J Urol (1982) 0.96
Mutational analysis of the C-terminal region of AREA, the transcription factor mediating nitrogen metabolite repression in Aspergillus nidulans. Mol Gen Genet (1996) 0.95
Expression of erbB-3 protein in colorectal adenocarcinoma: correlation with poor survival. J Cancer Res Clin Oncol (2000) 0.94
Growth control of prostatic carcinoma cells in serum-free media: interrelationship of hormone response, cell density, and nutrient media. Proc Natl Acad Sci U S A (1981) 0.94
Identification of the poor risk patient with "prostatism" and detrusor failure. Br J Urol (1986) 0.92
Seminal vesicle tumours. J R Soc Med (1978) 0.92
Prostatectomy or conservative management in the treatment of benign prostatic hypertrophy? Br J Urol (1988) 0.92
The effect of 5-azadeoxycytidine on cell growth and DNA methylation. Biochim Biophys Acta (1982) 0.92
Early observations of the effect of extracorporeal shockwave lithotripsy on blood pressure: a prospective randomized control clinical trial. BJU Int (2000) 0.91
Silent pyonephrosis as a cause of chronic ill-health. Lancet (1982) 0.91
The identification of patients at risk from acute retention. Br J Urol (1980) 0.90
Metabolic changes in rat brain following intracerebroventricular injections of streptozotocin: a model of sporadic Alzheimer's disease. Acta Neurochir Suppl (2010) 0.89
Enhanced expression of the mesenchymal marker, vimentin, in hyperplastic versus normal human prostatic epithelium. J Urol (1998) 0.89
Intravascular complications of transurethral resection of the prostate. Br J Urol (1982) 0.88
The contribution of research to urological training in the United Kingdom. Br J Urol (1998) 0.88
Excretion urography in the investigation of prostatism. Br J Urol (1976) 0.87
Metabolic effects of oestrogen treatment in patients with carcinoma of prostate: a comparison of stilboestrol and conjugated equine oestrogens. Br Med J (1973) 0.87
Noninvasive detection of nonsteroidal anti-inflammatory drug-induced gastropathy in dogs. Am J Vet Res (1995) 0.87
Urethral closure in management of urinary incontinence. Urology (1989) 0.87
Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group. Postgrad Med J (1995) 0.86
Fatal anaerobic infection following transrectal biopsy of a rare prostatic tumour. Br J Urol (1993) 0.86
Haemospermia. Br J Urol (1992) 0.85
Diagnosis and management of early prostate cancer. Report of a British association of urological surgeons working party. BJU Int (1999) 0.85
Detrusor myectomy for detrusor overactivity: a minimum 1-year follow-up. Br J Urol (1998) 0.85
DeltaNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation. Cell Death Differ (2004) 0.85
Effects of topically potent glucocorticoids on human diploid fibroblasts in vitro. Br J Dermatol (1977) 0.84
Detection and distribution of heat shock proteins 27 and 90 in human benign and malignant prostatic tissue. Br J Urol (1996) 0.84
The management of vesicoureteric reflux in children. Br J Urol (1978) 0.84
A colorimetric assay for the assessment of cytotoxicity of yeasts. Sabouraudia (1984) 0.84
Shunting is a translation strategy used by plant pararetroviruses (Caulimoviridae). Micron (2001) 0.84
Proceedings: Electrical activity of human colonic smooth muscle in vitro. J Physiol (1976) 0.83
Modulation of growth of a human prostatic cancer cell line (PC-3) in agar culture by normal human lung fibroblasts. Cancer Res (1981) 0.83
Simultaneous functional magnetic resonance imaging in the rat spinal cord and brain. Exp Neurol (2005) 0.82
Eukaryotic DNA methylase--properties and action on native DNA and chromatin. Curr Top Microbiol Immunol (1984) 0.82
Infarction of the testis: a complication of epididymitis. Br J Urol (1982) 0.82
Postoperative urinary tract infections in urology and gynaecology: a review. J R Soc Med (1980) 0.82
Hibitane bladder irrigation in the prevention of catheter-associated urinary infection. Br J Urol (1979) 0.82
Combining a targeted radiotherapy and gene therapy approach for adenocarcinoma of prostate. Prostate Cancer Prostatic Dis (2004) 0.82
Arterial embolisation in renal carcinoma: a useful procedure? Br J Urol (1982) 0.82
Legal pitfalls in the diagnosis of prostate cancer. BJU Int (2000) 0.82
Idiotype-anti-idiotype interactions of VHIX-coded anti-progesterone and anti-arsonate antibodies. Comparison of passive haemagglutination and radioimmunoassays. Scand J Immunol (1987) 0.82
A multi-centre phase two study of intravesical epirubicin in the treatment of superficial bladder tumour. Eur Urol (1990) 0.81
Comparison of silicone and latex catheters in the development of urethral stricture after cardiac surgery. Br J Urol (1986) 0.81
Franzen-positive carcinoma of the prostate in histologically benign glands. Cancer Detect Prev (1982) 0.81
Growth, DNA repair, sister chromatid exchange and chromosome studies in fibroblasts from Huntington's disease patients. Ann Hum Genet (1981) 0.81
Two types of sheep Peyer's patches: location along gut does not influence involution. Immunology (1989) 0.81
Selective growth of normal adult human urothelial cells in serum-free medium. In Vitro Cell Dev Biol (1985) 0.81
Transitional cell carcinoma of the prostate. Br J Urol (1979) 0.80
Multi-centre phase II study of low dose intravesical epirubicin in the treatment of superficial bladder cancer. Yorkshire and Scottish Urological Cancer Research Groups. Br J Urol (1991) 0.80
The long-term results of ileal conduit urinary diversion in children. Br J Urol (1979) 0.80
Late results in the management of primary pelvic hydronephrosis. Br J Urol (1972) 0.80